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Abstract 
 
A striking characteristic of the highly successful techniques in molecular biology is that they are 
derived from natural systems. RNA interference (RNAi), for example, utilises a mechanism that 
evolved in eukaryotes to destroy foreign nucleic acid. Other examples include restriction 
enzymes, the polymerase chain reaction, green fluorescent protein and CRISPR-Cas. I propose 
that biologists exploit natural molecular mechanisms for their effectors’ (protein or nucleic acid) 
activity and biological specificity (protein or nucleic acid can cause precise reactions). I also show 
that the developmental trajectory of novel techniques in molecular biology, such as RNAi, is four 
characteristic phases. The first phase is discovery of a biological phenomenon, typically as 
curiosity driven research. The second is identification of the mechanism’s trigger(s), the effector 
and biological specificity. The third is the application of the technique. The final phase is the 
maturation and refinement of the molecular biology technique. The development of new 
molecular biology techniques from nature is crucial for biological research. These techniques 
transform scientific knowledge and generate new knowledge.  
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Introduction 
 
Molecular biology is principally concerned with explaining the complex molecular phenomena 
underlying living processes by identifying the mechanisms that produce such processes (Tabery 
et al. 2015). In order to access the causal structure of molecular mechanisms it is generally 
necessary to manipulate the components of the mechanism and to observe the resulting effects 
with sophisticated molecular techniques. These techniques generate knowledge that cannot be 
obtained by any other means. Therefore, scientific knowledge in molecular biology advances in a 
distinctive way: progress is driven by the introduction and use of novel techniques. However, 
what drives the development of molecular biology techniques?  
 
In this paper, I firstly provide evidence that highly successful molecular biology techniques are 
derived from natural systems. In Section 2, I explain how the natural systems’ strategy for 
technique development means that the techniques utilise the activity of a mechanism’s effector 
(protein or RNA) and exploit biological specificity (protein or nucleic acid can cause precise 
reactions). In Section 3, I present RNA interference (RNAi) as an exemplar case study to 
describe how molecular biology techniques are typically developed from nature. In Section 4, I 
show that molecular biology technique development can be divided into four phases. I conclude 
by discussing the implications of deriving techniques from nature for molecular biology. 
  
 
1) From natural systems to techniques 
 
A striking feature of the development of molecular biology techniques, which biologists 
themselves often highlight (for example, Lander 2016; Mello and Conte 2004), is that they are 
derived from natural systems. These techniques are not developed through rational design. In 
this paper I identify eight highly successful techniques of molecular biology that are derived from 
natural systems. In chronological order these are: restriction enzymes; DNA sequencing, 
polymerase chain reaction (PCR); gene targeting; green fluorescent protein (GFP); RNAi; 
induced pluripotent stem cells (iPS); and clustered regularly interspaced short palindromic 
repeats-CRISPR associated (CRISPR-Cas) (see Table 1). Throughout this paper I draw on RNAi 
as my detailed case study due to my firsthand experience with this technique (Ronai et al. 2016). 
RNAi is a technique that introduces molecules of RNA into an organism in order to reduce the 
expression of a gene of interest (reviewed in, Mello and Conte 2004) (Figure 1). The eight 
molecular biology techniques are so ubiquitous that they are regarded as common knowledge by 
biologists. So when these techniques are mentioned in the Methods section of a scientific article, 
a citation to the technique is often not necessary (for example, Ronai et al. 2016). 
 
The eight molecular biology techniques discussed are derived from mechanisms that each 
evolved for a particular biological function in a natural system (see Table 1). The biological 
function of the RNAi mechanism, for example, is an organismal defence system for the 
destruction of foreign nucleic acid and mobile elements (van Rij and Andino 2006; Waterhouse 
et al. 1998; Waterhouse et al. 2001). Interestingly, the RNAi mechanism is thought to have been 
co-opted (Cerutti and Casas-Mollano 2006) for the precise regulation of endogenous gene 
expression, in particular for the regulation of developmental genes (Carrington and Ambros 
2003). Therefore, the RNAi mechanism is a deeply entrenched process in eukaryotic organisms. 
The same biological function, to destroy foreign nucleic acid in the organism, underlies the 
techniques of RNAi (derived from eukaryotes) and CRISPR-Cas (derived from prokaryotes) 
(Bhaya et al. 2011; Wright et al. 2016), but the two techniques involve different molecular 
mechanisms (Table 1). Therefore, the ‘arms race’ that occurs between viruses and their 
organismal hosts has provided biologists with the basis of two techniques. In contrast the  
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Fig. 1: A model of the molecular biology technique of RNA interference (RNAi). (1) Double-
stranded RNA (dsRNA) is introduced into the experimental system. (2) The endogenous 
endonuclease Dicer cleaves the dsRNA into small fragments known as small interfering RNA 
(siRNA). (3) Or the siRNA is added directly into the experimental system. (4) The siRNA 
antisense strand attaches to the endogenous RNA-induced silencing complex (RISC), (5) which 
binds sequence specifically to the target mRNA. (6) RISC cuts the target mRNA which causes it 
to be degraded, therefore no gene function is executed.  
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Table 1: Summary and characterisation of eight pivotal molecular biology techniques. These 
techniques are all derived from natural systems and are now utilised as methodologies. For key 
references see Table 2. 
 
Technique (in 
chronological 
order of 
development) 
Originating 
natural 
system 
Biological 
function of 
mechanism 
Experimental 
context 
Type of effector  Type of biological 
specificity 
1. Restriction 
enzymes 
Bacteria Destroy foreign 
nucleic acid from 
bacteriophages 
In vitro Restriction 
endonuclease 
Stereochemical: DNA 
recognition sequence 
2. DNA 
sequencing 
Bacteria DNA replication In vitro DNA polymerase I Informational: 
dideoxynucleotides (also 
DNA primer) has 
sequence match to DNA 
template 
3. PCR Bacteria DNA replication In vitro DNA polymerase I Informational: DNA 
primers has sequence 
match to DNA template 
4. Gene 
targeting 
Organism or 
cell culture 
Homologous 
recombination 
Organisms & 
cell culture 
Endogenous 
endonuclease (for 
example, SPO11) 
Informational: 
exogenous DNA has 
sequence match to target 
DNA/gene 
5. GFP Jellyfish Unknown - 
emitted when 
jellyfish is agitated 
(Davenport and 
Nicol 1955) 
Organisms & 
cell culture 
Green fluorescent 
protein (GFP), in 
particular the 
flurophore 
Engineered 
informational specificity: 
GFP DNA placed in 
specific location 
6. RNAi Eukaryote or 
cell culture 
Destroy foreign 
nucleic acid or 
gene regulation 
Eukaryote 
organisms & 
cell culture 
Endogenous RNA-
induced silencing 
complex (RISC), in 
particular the 
Argonaute 
endonuclease 
Informational: dsRNA 
(& siRNA) with 
sequence match to target 
mRNA 
7. iPS Embryonic 
stem cells 
Stem cell function 
(unlimited self-
renewal & 
pluripotency) 
Cell culture Transcription 
factors (Oct4, Sox2, 
cMyc & Klf4)  
Stereochemical: DNA 
binding site  
8. CRISPR-Cas Bacteria Destroy foreign 
nucleic acid from 
bacteriophages 
Organisms & 
cell culture 
RNA-guided DNA 
endonuclease (cas9)  
Informational: guide 
RNA (crRNA + 
tracrRNA) with 
sequence match to target 
DNA 
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technique of GFP is derived from a relatively unique biological phenomenon in jellyfish and is 
therefore taxonomically restricted.  
 
As is usual in biological research practice, when a molecular biology technique is developed for 
an organismal experimental context (Table 1) it is first tested in a ‘model organism’ system. 
Model organisms provide standardised experimental systems that are relatively well characterised 
at the molecular level act as a prototype for technique development (Ankeny 2000). This is 
particularly important given the complexity and cost of molecular biology experiments. The 
expectation is that, due to the fundamental unity of living systems, if a technique is validated in a 
model organism, then it will be possible to apply it to other organisms. For example, RNAi was 
first developed using the model organism Caenorhabditis elegans (Fire et al. 1998). 
 
The explanatory focus of biology is what occurs in nature so experiments must be compatible 
with living processes (Weber forthcoming) rather than create artificial phenomena. Therefore, 
the use of pre-existing, natural mechanisms for technique development in molecular biology is 
advantageous. These techniques are compatible with other biological processes and able to 
operate within a cellular context. Furthermore, the use of a natural mechanism may allow the 
continuing function of the biological process (for example, GFP) and cellular based techniques 
can be stably inherited in designed constructs with transgenerational effects. These techniques 
can be used to observe or intervene in active, complex biological processes even when no 
comprehensive understanding of these processes exists. 
 
 
2) The importance of natural systems for the development of 
techniques in molecular biology  
 
In this section I analyse why natural systems are used for the development of techniques in 
molecular biology. Natural mechanisms have been selected and optimised by evolution. These 
mechanisms therefore have a high level of validation. Molecular biology techniques exploit two 
characteristics of natural mechanisms: an effector’s activity and the use of biological specificity. 
 
  
2.1) Effector activity 
 
Living systems use effectors (such as, proteins or RNAs) to generate a particular activity within a 
mechanism. I have identified the protein effector, all from a natural system, for each of my eight 
molecular biology techniques (Table 1). The majority of the techniques utilise proteins that are 
catalytic enzymes (note, enzyme names normally end with '-ase') and the techniques leverage the 
efficiency of the enzymatic activity (Table 1). The two exceptions are the techniques of GFP and 
iPS which utilise a protein’s stereochemistry, a flurophore or structural motif, respectively (Table 
1).  
 
The technique’s effector is either endogenous or exogenous to the experimental system (Table 
1). Endogenous based techniques use the effector for its original purpose but they co-opt the 
overall mechanism. Whereas, exogenous based techniques use the effector for its original 
purpose but in another biological context, so the effector needs to be introduced into the 
experimental system. For example, the effector of RNAi is the RNA-induced silencing complex 
(RISC), which is an endogenous component of a molecular mechanism present in all eukaryotes 
and involves an enzyme (Cerutti and Casas-Mollano 2006). RISC cuts the target mRNA and 
cause it to be degraded (Hammond et al. 2000; Martinez et al. 2002). 
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2.2) Biological specificity 
 
Living systems need biological specificity to achieve fine-grained control over their molecular 
mechanisms (Griffiths et al. 2015; Waters 2007; Woodward 2010). Biologists artificially introduce 
biological specificity into their experimental systems. The eight molecular biology techniques 
studied here utilise this biological specificity to precisely access the target mechanism with 
minimal off-target events. Drawing on this specificity means that the technique can be 
multiplexed (multiple nucleic acid sites targeted at the same time). I have identified that the 
majority of the eight molecular biology techniques use nucleic acid sequence informational 
specificity (Griffiths and Stotz 2013), nucleic acid is the substrate of the mechanism (Table 1). 
For example, RNAi uses nucleic acid specificity when double-stranded RNA (dsRNA) or small 
interfering RNA (siRNA) is introduced into the experimental system and binds sequence 
specifically to the target mRNA. One molecular biology technique (GFP) uses what I have 
termed ‘engineered informational specificity’, where the biologist creates the specificity by 
placing the effector in a highly specific location. Two other molecular biology techniques, iPS 
and restriction enzymes, use protein stereochemical specificity (Griffiths and Stotz 2013) (Table 
1).  
 
For nucleic acid guided techniques the informational specificity is artificially designed whereas 
stereochemical specificity uses natural specificity. Therefore, stereochemical specificity is fixed 
before the start of the experiment and is less programmable than informational specificity. 
 
Before RNAi was developed as a technique only a non-specific, permanent disruption in gene 
expression via mutagenesis was possible (Bellés 2010). In contrast, RNAi provides more fine-
grained control because it uses nucleic acid sequence informational specificity. A biologist 
introduces RNA molecules into the experimental system which initiates the mechanism and its 
nucleotide sequence specifies the mRNA sequence to degrade. Therefore, RNAi manipulates 
gene expression at a fine scale to cause a ‘knockdown’ in gene expression. In addition, RNAi can 
be ‘multiplexed’ as different RNA molecules can be introduced in order to target different 
mRNAs (see for example, Fellmann and Lowe 2014; Kennerdell and Carthew 1998), or the same 
mRNA in different regions (see for example, Gou et al. 2007). Furthermore, in nature dsRNA 
acts as a natural multiplexer because it is cut into multiple siRNAs that target different regions of 
the mRNA (Bernstein et al. 2001). 
 
 
2.3) The importance of an effector’s activity and biological specificity 
 
The effector activity and specificity of a technique are critical to its success. If there are multiple 
techniques available to achieve the same experimental purpose, then the one with the greatest 
efficiency or superior type of specificity is preferred by the scientific community. For example, 
transcription activator-like effector nucleases (TALENs) are a technique derived from the 
bacteria Xanthomonas (Boch et al. 2009; Moscou and Bogdanove 2009). TALENs are similar to 
the CRISPR-Cas technique, as both are used for DNA editing. However, a TALENs’ specificity 
is stereochemical so it needs to be reengineered for every experiment. Therefore, TALENs are 
not as easily programmable for a wide range of targets compared to CRISPR-Cas (with the 
notable limitation of the protospacer adjacent motif (Doudna and Charpentier 2014)). For this 
reason CRISPR-Cas became commercially viable and has replaced TALENs as the premier gene 
editing technique (Corbyn 2015; Doudna and Charpentier 2014). Therefore, the effector’s 
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activity and specificity are likely to be critical for the commercialisation of the technique for 
widespread usage. 
 
Note that biologists implicitly recognise the importance of the effector’s activity and the use of 
biological specificity for their molecular biology techniques. For example, many studies on RNAi 
discuss the technique’s effector’s activity (Fellmann and Lowe 2014; Filipowicz et al. 2005; Li et 
al. 2006; Rana 2007; Siomi and Siomi 2009; Vaucheret et al. 1998) and specificity (Bartel 2004; 
Elbashir et al. 2001b; Fellmann and Lowe 2014; Fire et al. 1998; Hamilton and Baulcombe 1999; 
Hammond et al. 2000; Hammond et al. 2001; Kennerdell and Carthew 1998; Parrish et al. 2000; 
Rana 2007; Siomi and Siomi 2009; Waterhouse et al. 1998; Waterhouse et al. 2001). In this 
section I have made theoretically explicit these two key characteristics of natural mechanisms: an 
effector’s activity and the use of biological specificity. 
 
 
3) RNAi: a case study 
 
To answer the question of how a molecular biology technique is derived from nature requires an 
in-depth examination of how techniques are developed. In this section I describe in detail how 
the technique of RNAi was developed. 
 
The development of RNAi was preceded by observations of gene-specific transcriptional 
inhibition when synthetic antisense RNA was introduced into an organism. Experiments in the 
bacteria Escherichia coli indicated that antisense RNA could bind to and inactivate mRNA (Light 
and Molin 1982). This phenomenon was then observed in many different organisms, including 
the nematode worm Caenorhabditis elegans (Izant and Weintraub 1984) and plants (Ecker and 
Davis 1986). At the same time, plant virologists showed that when a viral transgene was 
introduced into a plant the plant became resistant to the virus (Abel et al. 1986). These studies 
suggested that gene expression could be manipulated with the introduction of RNA. 
 
Early studies discovered the RNAi mechanism in many different organisms, but the first study 
was conducted in plants. Napoli et al. (1990); van der Krol et al. (1990) wanted to increase colour 
intensity in the Petunia hybrida flower. They introduced a transgene (sense RNA) into the plant in 
order to overexpress a gene in the anthocyanin pathway, which controls formation of the flower 
pigment. Contrary to expectation, transformed flowers had less, rather than more, pigment. The 
synthetic sense RNA had reduced the mRNA of the endogenous gene. They termed this 
phenomenon ‘co-suppression’ (Napoli et al. 1990). In addition, Romano and Macino (1992) 
identified the RNAi phenomenon in a fungus, Neurospora crassa, and termed it ‘quelling’. Also, 
studies in plants demonstrated that silencing occurred post-transcriptionally and therefore the 
RNAi phenomenon was sometimes referred to as ‘post transcriptional gene silencing’ (Blokland 
et al. 1994). At this time multiple studies were conducted on the introduction of RNA into C. 
elegans (Fire et al. 1991) (Fire et al. 1991; Guedes and Priess 1997; Guo and Kemphues 1995; Lin 
et al. 1995; Mello et al. 1996; Powell-Coffman et al. 1996). One of these C. elegans studies coined 
the term ‘RNA-mediated interference’ (Rocheleau et al. 1997). It is important to note that at this 
time microRNAs (miRNA), which are transcribed from the endogenous DNA and use the RNAi 
mechanism to regulate gene expression, were also identified (Lee et al. 1993; Wightman et al. 
1993). These successive studies into how an organism actively responds to the introduction of 
RNA produced knowledge that was critical to the development of RNAi.  
 
The RNAi technique was first applied in the paper ‘Potent and specific genetic interference by 
double-stranded RNA in Caenorhabditis elegans’ published in the journal Nature (Fire et al. 1998). 
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In Fire et al. (1998, p. 807) dsRNA was investigated due to it being a contaminant in earlier 
experiments as it was found that:  
… polymerases, although highly specific, produce some random or ectopic transcripts. 
DNA transgene arrays also produce a fraction of aberrant RNA products3… we 
surmised that the interfering RNA populations might include some molecules with 
double-stranded character. 
dsRNA was accidently produced in these earlier experiments and caused the gene silencing.  
 
Fire et al. (1998, p. 806) investigated dsRNA and identified that it is causally specific for the 
RNAi mechanism, they:  
… investigate[d] the requirements for structure and delivery of the interfering RNA. To 
our surprise, we found that double-stranded RNA was substantially more effective at 
producing interference than was either strand individually. 
Therefore, the study tested the specificity of RNA molecules to control the RNAi mechanism. 
The study was also a conclusive demonstration of how dsRNA can be used to control the RNAi 
mechanism and applied as a molecular biology technique to manipulate gene expression. Fire et 
al. (1998, p. 810) concluded that RNAi: 
… adds to the tools available for studying gene function in C. elegans. In particular, it 
should now be possible functionally to analyse many interesting coding regions21 for 
which no specific function has been defined.   
Interestingly, Fire et al. (1998, p. 810) did not understand the biological function of the RNAi 
mechanism:  
Whatever their target, the mechanisms underlying RNA interference probably exist for a 
biological purpose. 
 
Immediately following publication of the Fire et al. (1998) paper, RNAi was shown to work in 
multiple organisms. Studies rapidly emerged describing RNAi’s effectiveness in C. elegans 
(Fitzgerald and Schwarzbauer 1998; Montgomery et al. 1998; Ogg and Ruvkun 1998; Page and 
Winter 1998; Skop and White 1998; Tabuse et al. 1998; Timmons and Fire 1998); two species of 
plants, Nicotiana tabaccum and Oryza sativa (Waterhouse et al. 1998); and D. melanogaster 
(Kennerdell and Carthew 1998). Attempts to conduct RNAi in mammals initially failed due to 
the immune response elicited, however, when siRNAs were introduced instead of dsRNA gene 
silencing occurred (Elbashir et al. 2001a). RNAi became a highly selective molecular biology 
technique for reducing expression of a target gene and today it is widely used for both basic and 
applied research (Deng et al. 2014; Fellmann and Lowe 2014; Mello and Conte 2004).  
 
In the years following the Fire et al. (1998) paper, many components of the RNAi mechanism 
were identified and characterised. Biologists wondered how dsRNA could bind to the mRNA to 
cleave it and why a complete antisense RNA had never been detected in vivo. Biologists set out 
to look for fragments of the antisense RNA. They found small RNA fragments (antisense and 
sense) in plants and suggested that these were the molecules necessary for RNAi (Hamilton and 
Baulcombe 1999). Biologists also found that dsRNA is processed into small RNA fragments in 
D. melanogaster cells (Hammond et al. 2000; Zamore et al. 2000) and in C. elegans (Parrish et al. 
2000). Small interfering RNAs (siRNA), 21-23 nucleotides in length, were identified as the 
common intermediary and their specificity guided the cleavage of the mRNA (Elbashir et al. 
2001b). Biologists then needed to identify effectors for two distinct mechanistic steps: how 
dsRNA is cleaved into siRNA; and how the target mRNA is degraded.  
 
The enzyme that cleaves a dsRNA into siRNAs was identified as a ribonuclease type III named 
Dicer (Bernstein et al. 2001). The endonuclease that cuts the target mRNA sequence-specifically 
was identified as Argonaute, which is part of the RNA-induced silencing complex (RISC) 
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(Hammond et al. 2000; Martinez et al. 2002). Biologists then pursued the mechanistic details 
such as the functions of different forms of Dicer and Argonaute and how RISC works (Rana 
2007). To this day the mechanism of RNAi is still being investigated. 
 
In the following section I use the history of RNAi as the basis for an account of molecular 
biology technique development. I show that technique development can be demarcated into 
phases. 
 
 
4) Molecular biology technique development has four phases 
 
I propose that molecular biology techniques derived from natural systems have a specific pattern 
of development with four critical phases. These phases are: the discovery of a phenomenon; 
identification of the mechanism’s trigger(s); application of the technique; and maturation of the 
technique. The eight molecular biology techniques I have explored in this paper show the four 
phases of technique development (Table 2).  
 
The first phase is discovery - an interesting phenomenon is identified in a natural system. 
Biologists are curiosity driven and routinely identify and describe unusual phenomena. However, 
at this stage the underlying mechanism is not well characterised and the biological function of 
the mechanism is typically unknown. 
 
The second phase is the identification of the trigger(s). The effector component of the 
mechanism is identified and the specificity is identified (see Table 3A&B), note that for 
stereochemical techniques the effector is the specificity. If the effector is endogenous to the 
experimental system, then it does not need to be added to the experiment and its identification is 
not essential for the development of the technique. For example, the RNAi effector component 
was identified two years after the RNAi technique was developed (Table 2). I term the effector 
and specificity ‘the trigger(s)’ because they are the key causative agents and are ‘the causally 
specific actual difference maker’ under typical conditions (Carrier 2004; Waters 2007; Woodward 
2010). Once biologists identify the trigger(s) they can use it to precisely access the causal 
structure of the mechanism. 
 
The third phase is application of the trigger(s). In a conclusive demonstration that the trigger(s) 
is introduced into the experimental system and achieves some intended effect on the target of 
the specificity. The trigger(s) is exploited in three types of investigative strategies: to manipulate 
an effector’s activity in a non-cellular experimental system, for example, restriction enzymes; to 
intervene on a cellular experimental system, for example, RNAi; or as a tracer to follow a natural 
process (for an in depth discussion see Griesemer 2007), for example, GFP (Table 1). At this 
stage a deep understanding of the mechanism underlying the technique is not necessary for the 
technique to work. 
 
The fourth phase is maturation. Once the technique is established its performance can be 
improved. The scientific community invests considerable research activity into characterising, 
both spatially and temporally, the mechanism in natural systems. Therefore, the technique 
generates further research on the mechanism that underlies it. The new knowledge acquired may 
improve access to the mechanism or allow the technique to be better controlled, enabling the 
technique to continue to be refined. 
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Table 2: The four phases of development for the eight highly successful molecular biology 
techniques. For each technique I identify the first paper that: discovered the phenomenon; 
identified the mechanism’s effector; identified the mechanism’s specificity applied the trigger(s); 
and any highly cited papers that demonstrate the maturation of the technique.  
 
Technique (in 
chronological 
order of 
development) 
Phase Reference Description 
1. Restriction 
enzymes 
Discovery Luria and Human 
(1952) 
Discovered that bacteriophage (T1, T2, T3, T4, T5, 
T6 and T7) vary in their ability to grow in different 
bacterial (Escherichia coli and Shigella dysenteriae) strains. 
Dussoix and Arber 
(1962) 
Discovered that bacteriophage λ DNA degrades in 
Escherichia coli strains. 
Identification of 
specificity/effector 
Kelly Jr and Smith 
(1970); Smith and 
Welcox (1970)1 
Identified the nucleotide recognition sequence that 
causes restriction enzymes (in particular, a type II 
which recognises DNA and cuts sites at the same 
place, endonuclease R from Hemophilus influenza) to 
cut DNA. 
Application of trigger Danna and 
Nathans (1971) 
Applied restriction enzyme (endonuclease R from 
Hemophilus influenza) to cut up DNA. 
Maturation Feinberg and 
Vogelstein (1983) 
Developed restriction enzymes using radiolabelling to 
efficiently recover DNA fragments. 
2. DNA 
sequencing 
Discovery Watson and Crick 
(1953) 
Discovered the complementary DNA structure in calf 
thymus (possibly) and proposed a mechanism for 
DNA replication. Also, predicted the existence of 
DNA polymerase. 
Identification of 
effector 
Kornberg et al. 
(1956b) 
Identified DNA polymerase in Escherichia coli. 
Identification of 
specificity 
Atkinson et al. 
(1969) 
Identified that dideoxynucleotides cause DNA 
polymerase to terminate synthesis of DNA.  
Application of triggers Sanger et al. (1977) Applied dideoxynucleotides with DNA polymerase 
from Escherichia coli to determine the DNA sequence 
of bacteriophage φX174. 
Maturation The C. elegans 
Sequencing 
Consortium (1998) 
Developed DNA (Sanger) sequencing to sequence the 
first multicellular organism (Caenorhabditis elegans) 
genome. 
International 
Human Genome 
Sequencing 
Consortium (2001) 
Developed DNA (Sanger) sequencing to sequence the 
human genome. 
3. PCR Discovery Watson and Crick 
(1953) 
Discovered the complementary DNA structure in calf 
thymus (possibly) and proposed a mechanism for 
DNA replication. Also, predicted the existence of 
DNA polymerase. 
Identification of 
effector 
Kornberg et al. 
(1956b) 
Identified DNA polymerase in Escherichia coli. 
Identification of 
specificity 
Kornberg et al. 
(1956a) 
Identified that a primer causes DNA polymerase to 
initiate synthesis of DNA. 
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Application of triggers Kleppe et al. 
(1971)2 
Applied primers with DNA polymerase from 3 
species (Escherichia coli, Microccus luteus and T4) to 
replicate short synthetic DNA. 
Saiki et al. (1985) Applied primers with DNA polymerase from 
Escherichia coli to amplify DNA region. 
Maturation Saiki et al. (1988) Developed PCR to be thermostable using DNA 
polymerase from Thermus aquaticus. 
4. Gene targeting Discovery Gluzman et al. 
(1977); Vogel et al. 
(1977)1 
Discovered that a mutant phenotype can be rescued 
in a simian virus 40 (SV40) temperature-sensitive 
mutant (tsD202) when added to monkey CV1 cells 
(containing endogenous integrated SV40). Also, 
discovered that the rescue is due to recombination. 
Identification of 
specificity 
Hinnen et al. 
(1978) 
Identified that exogenous DNA of LEU2 causes site 
specific recombination with homologous 
chromosomal DNA in Saccharomyces cerevisiae. 
Application of trigger Smithies et al. 
(1985) 
Applied exogenous DNA to modify only the target 
gene (β-globin) in human cells. 
Maturation Thomas and 
Capecchi (1987) 
Developed gene targeting to inactivate an endogenous 
gene (hptr) in mouse embryonic stem cells.  
Doetschman et al. 
(1987) 
Developed gene targeting to correct mutant hptr in 
mouse embryonic stem cells. 
Mansour et al. 
(1988) 
Developed gene targeting selection (positive for cells 
that have incorporated exogenous DNA and negative 
for cells that have randomly incorporated exogenous 
DNA) in mouse embryonic stem cells. 
Identification of 
effector 
N/A3 Endogenous endonucleases create a double-stranded 
break and this initiates repair pathway. For example, 
SPO11. 
5. GFP Discovery Davenport and 
Nicol (1955) 
Discovered the green fluorescence in Aequorea victoria. 
Identification of 
effector 
Shimomura et al. 
(1962) 
Identified GFP in Aequorea victoria. 
Identification of 
specificity 
Prasher et al. 
(1992) 
Identified the genomic DNA and cDNA sequence of 
GFP that causes fluorescence in Aequorea victoria. 
Application of trigger Chalfie et al. 
(1994) 
Applied GFP cDNA to generate fluorescence in E. 
coli and Caenorhabditis elegans cells. 
Maturation Heim et al. (1995) Developed GFP spectral characteristics using a point 
mutation in Escherichia coli. 
Cormack et al. 
(1996) 
Developed GFP variants that fluoresce more 
intensely in Escherichia coli. 
6. RNAi Discovery Napoli et al. (1990) Discovered the knockdown of chalcone synthase in 
Petunia hybrida. 
Identification of 
specificity (1st step) & 
application of trigger 
Fire et al. (1998) Identified that dsRNA causes sequence specific 
regulation of mRNA in Caenorhabditis elegans.  
Applied dsRNA to knockdown gene expression in 
Caenorhabditis elegans. 
Identification of 
specificity (2nd step) 
Hamilton and 
Baulcombe (1999) 
Identified that siRNA (processed product of dsRNA) 
causes sequence specific regulation of mRNA in 
plants. 
Identification of 
effector 
Hammond et al. 
(2000) 
Identified the RNA-induced silencing complex (RISC) 
which contains an endonuclease that cleaves target 
mRNA in Drosophila cells. 
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Maturation Elbashir et al. 
(2001a) 
Developed RNAi to knockdown gene expression in 
mammalian and Drosophila cells. 
7. iPS Discovery Gurdon (1962) Discovered that cell differentiation is reversible 
because the nucleus of a somatic cell can successfully 
replace the nucleus of an egg cell in Xenopus laevis. 
Identification of 
specificity/effector & 
application of trigger 
Takahashi and 
Yamanaka (2006) 
Identified the genome and transcriptome changes that 
cause four transcription factors (Oct3/4, Sox2, c-Myc 
and Klf4 in mice) to make somatic cells become 
pluripotent stem cells.  
Applied the four transcription factors cDNA to 
reprogram embryonic and adult fibroblast mice cells. 
Maturation Takahashi et al. 
(2007) 
Developed iPS in human cells. 
8. CRISPR-Cas Discovery Ishino et al. (1987) Discovered the CRISPR motif (repeated sequence 
with spacers) in the DNA sequence of Escherichia coli. 
Identification of 
effector 
Makarova et al. 
(2002) 
Identified the CRISPR-associated (cas) genes in the 
genome sequences of bacteria and archaea. In 
particular, the class 2, Type II (recognises DNA and 
cleavage results in double-stranded break) Cas9 
(COG3513) in Streptococcus pyogenes, Campylobacter jejuni, 
Neisseria meningitidis and Pasteurella multocida. 
Identification of 
specificity (part 1) 
Brouns et al. 
(2008) 
Identified that CRISPR RNAs (crRNAs) causes Cas 
to sequence specifically cleave DNA in Escherichia coli. 
Identification of 
specificity (part 2) & 
application of triggers 
Jinek et al. (2012) Identified that crRNA and trans-activating CRISPR 
RNA (tracrRNA) must complementary base pair to 
cause Cas to site-specifically cleave DNA. 
Applied a tracrRNA-crRNA complex (the ‘single-
guide RNA’) with Cas9 from Streptococcus pyogenes to 
cleave DNA. 
Maturation Cong et al. (2013) Developed CRISPR-Cas to edit the genome of 
mammalian (human and mouse) cells. 
Mali et al. (2013) 
1 This paper was published in two parts. 
2 This study only applied primers with DNA polymerase to synthesise DNA rather than amplify 
a DNA region. 
3 A single study cannot be identified because the biological mechanism underlying gene targeting 
has multiple effectors.  
13 
 
Table 3: The key experiments for the RNAi technique conducted by Fire et al. (1998). 
Experiments that (A) identified the triggers in the RNAi mechanism; and (B) identified the target 
of the specificity in the RNAi mechanism. 
 
(A) 
Specificity Range tested Result 
Non-purified single-
stranded RNA 
(ssRNA) 
Sense RNA or antisense RNA When non-purified ssRNA was introduced into the experimental 
system RNAi occurred.  
Purified ssRNA Sense RNA or antisense RNA Purified ssRNA led to weaker RNAi compared to purified dsRNA, 
indicated that dsRNA causes RNAi. 
Complementary sense 
and antisense strand 
RNA 
Pre-annealed; injected 
sequentially; or injected 
sequentially but with long time 
interval between RNAs 
Pre-annealing of RNA led to stronger RNAi, indicated that the 
formation of dsRNA was important for RNAi. 
Sequential injection of sense and antisense RNA led to RNAi, 
indicated that RNA strands could hybridise to form dsRNA in the 
experimental system. 
If there was a long time interval between sequential injection of 
RNAs no RNAi occurred, indicated that over time ssRNA are 
degraded or become inaccessible in the experimental system.  
Time post-injection 
of RNA 
6; 15; 27; 41; or 56 hours When there was a long time interval after RNA was introduced into 
the experimental system RNAi decreased. 
ssRNA and control 
gene dsRNA 
ssRNA not attached to dsRNA; 
ssRNA attached at its 5’ end to 
dsRNA; or ssRNA attached at 
its 3’ end to dsRNA 
For the gene that the ssRNA targeted no RNAi occurred, indicated 
that sequence specificity not double stranded structure was 
important for RNAi. 
dsRNA length 299 to 1033 nucleotides Nucleotide length of dsRNA did not affect RNAi.  
RNA dosage 30,000 to 3,600,000 RNA 
molecules per organism 
Very low dsRNA dosages triggered RNAi, indicated that RNAi is a 
catalytic process (i.e. enzymes involved) otherwise there would be 
not enough RNA molecules to bind to all the endogenous mRNA in 
the experimental system.  
Site of injection of 
RNA in organism 
Body cavity of head; body 
cavity of tail; or gonad 
In tissues other than the ones injected RNAi occurred, indicated that 
RNAi is systemic. Also, injection of adults sometimes led to 
offspring with RNAi, indicated that trans-generational inheritance of 
RNAi occurred. These results suggested that the RNAi mechanism 
existed throughout the whole organism. 
 
(B) 
Target of specificity Range tested Result 
Gene regions One exon, 
multiple exons; 
intron; or 
promoter 
RNAi occurred only when the coding sequence of the mRNA was targeted, 
indicated that RNAi works through post-transcriptional regulation.  
Conserved gene 
segment 
 RNAi led to an unexpected phenotype, indicated that RNAi affects genes with a 
similar sequence to the gene of interest. 
Gene of interest unc-22; unc-54; fem-
1; hlh-1 ;gfp; or 
mex-3 
The target of RNAi was genes that are non-essential and have previously been 
characterised with an easily identifiable visual phenotype. Also, the relationship 
between the gene’s expression and phenotype was in the manipulable direction 
(i.e. reduced expression increased the severity of the phenotype). 
Transgenic line 
expressing two GFP 
reporter proteins 
 RNAi occurred in individual cells of the organism. 
mex-3 in an in situ 
hybridisation 
experiment 
 The target of RNAi was a gene that is abundant in early embryos (a useful 
developmental period for an in situ experiment). RNAi was demonstrated visually 
as the endogenous mRNA disappeared suggesting it was destroyed, indicated that 
mRNA (not precursor mRNA nor protein) was the target of RNAi. 
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4.1) Cognitive values and the success of the techniques 
 
Cognitive values play an important role in the assessment of theory change in the sciences 
(Darden 1991; Douglas 2013; Kuhn 1977). Here I identify the cognitive values that are important 
for the widespread adoption of a technique. Three cognitive values are important for the 
assessment of a technique. First, the technique needs to be fruitful for further research. 
Techniques need to generate new knowledge and open up areas of research that were previously 
unimaginable. For example, RNAi has helped biologists manipulate RNA thus leading to a more 
sophisticated understanding of the function of RNA (Mello and Conte 2004) and this has 
allowed biologists to manipulate genes that are lethal in development in order to investigate their 
functions (for example, Fitzgerald and Schwarzbauer 1998). Second, the technique should allow 
expansion of its scope of application far beyond its original biological context. After the effector 
protein is identified it must either be endogenous to the experimental system (and also conserved 
in the taxa that will be the experimental system) or be exogenous and able to operate in a range 
of experimental systems. A technique that has applications in many contexts means a bigger 
scientific community can use the technique. In addition, a technique that can be used in 
mammals is particularly desired due to the value placed on medical and therapeutic research. For 
example, the RNAi effector, RISC, is present in all eukaryotes (Cerutti and Casas-Mollano 2006) 
and RNAi can be used in human cell lines (Elbashir et al. 2001a). Third, the technique needs to 
have extendability. The technique should accommodate modifications so that it can be used for 
different or expanded capabilities. Therefore, a technique can become the progenitor for a family 
of related techniques. For example, a form of RNAi was developed that used RNA molecules 
targeted at promoters to increase rather than decrease gene expression (Li et al. 2006). It is 
important to note that whether a technique rates highly on these three cognitive values it can 
only be identified in hindsight as that judgment is based on the employment of the technique 
(Darden 1991; Douglas 2013). The three cognitive values I have identified do not compete with 
one another as similar theoretical values do (Darden 1991) - a technique can be fruitful, have 
broad scope and be extendable at the same time.  
 
 
5) Conclusions 
 
A deeper understanding of the characteristics of natural systems and the development of 
scientific practice is gained by examining how molecular biology techniques are developed by 
biologists. In this paper I have investigated eight highly successful techniques of molecular 
biology that are derived from natural systems. I have argued that the development of these 
techniques falls into four phases. What are the implications of the fact that biologists develop 
molecular biology techniques from natural systems? Biologists’ knowledge about natural systems 
limits what can be developed as a technique. Molecular biology techniques, and therefore 
molecular biology knowledge, are contingent. If biologists had discovered different phenomena 
in natural systems in the past then different techniques would have been developed. Molecular 
biology knowledge would have been altogether different, although we might speculate that 
deeply entrenched biological processes that are highly conserved across taxa (for example, the 
RNAi mechanism) will always be discovered. 
 
There are other molecular biology techniques that are derived from natural systems and are likely 
to use the four phases of development of a molecular technique. These include techniques such 
as: reverse transcription; molecular cloning; monoclonal antibodies; site directed mutagenesis; 
and immunotherapy. Further research could identify these techniques’ effector’s activity and 
specificity. 
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It is an open question whether molecular biology will continue to progress through the 
development of molecular techniques derived from natural systems. Perhaps knowledge 
construction in molecular biology requires a natural systems strategy. Alternatively, as a relatively 
immature science that is still discovering its fundamental phenomena, adopting this strategy 
could be just an immature stage for molecular biology. There is some evidence that biologists 
working on synthetic biology have started to use rational design in organisms, for example, the 
high profile ‘Human Genome Project–Write’ (Boeke et al. 2016). However, biologists often find 
that rational design is not optimal and that selection methods lead to improved technique 
development and outcomes (Silverman 2003). Furthermore, a rational design strategy cannot be 
used to access the causal structure of molecular mechanisms when no comprehensive 
understanding of these mechanisms exists. 
 
The addition of new molecular biology techniques accelerate research, transform biological 
knowledge and generates new knowledge that would otherwise not exist. A new technique can 
help uncover previously undetected phenomena and paradoxically, in turn lead to the 
development of yet another technique. Therefore, the techniques in molecular biology build 
upon one another and are cumulative.  
 
Perhaps it is the fact that molecular biology’s scientific practice is based on a collection of 
research tools, that makes it such a unique area of the biological sciences (Burian 1993). 
Biologists imbue their explanations of molecular mechanisms with the techniques they use to 
investigate the mechanisms (Trujillo et al. 2015). In molecular biology, even more than in other 
areas of science, the development of technological capabilities and scientific knowledge are 
inextricably linked.  
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